Factors | Number (%) |
---|---|
Age (years) | |
median (range) | 74 (46–88) |
Sex | |
Male | 51 (78) |
Female | 14 (22) |
PS | |
0 | 22 (34) |
1 | 39 (60) |
2 | 4 (6) |
Location of primary tumor | |
Right upper lobe | 23 (35) |
Right middle lobe | 4 (6) |
Right lower lobe | 17 (26) |
Left upper lobe | 16 (25) |
Left lower lobe | 5 (8) |
Clinical Stage | |
II A | 8 (12) |
II B | 29 (45) |
III A | 16 (25) |
III B | 12 (18) |
Histology | |
Squamous cell carcinoma | 35 (54) |
Adenocarcinoma | 26 (40) |
Large cell carcinoma | 2 (3) |
Non small-cell carcinoma | 2 (3) |
Total dose | |
68 Gy (RBE)/16 fr | 9 (14) |
72 Gy (RBE)/16 fr | 45 (69) |
76 Gy (RBE)/16 fr | 11 (17) |
Chemotherapy | |
Yes | 14 (22) |
No | 51 (78) |
Smoking status | |
Current or previous | 56 (86) |
Never | 9 (14) |
Pulmonary emphysema | |
Yes | 12 (18) |
No | 53 (82) |